Management of alopecia areata in JAK-inhibitors era: are systemic and topical corticosteroids still useful?

Int J Dermatol. 2023 Apr;62(4):e234-e236. doi: 10.1111/ijd.16500. Epub 2022 Nov 13.

Authors

Gaetano Licata¹, Vittorio Tancredi², Giulia Calabrese², Dario Buononato², Alina De Rosa², Giuseppe Argenziano², Alessio Gambardella²

Affiliations

¹ Dermatology Department, ASST Spedali Civili di Brescia, University of Brescia, Brescia, Italy.
² Dermatology Unit, Department of Mental and Physical Health and Preventive medicine, University of Campania Luigi Vanvitelli Naples, Italy.

PMID: 36371689
DOI: 10.1111/ijd.16500

No abstract available

Publication types

Letter
Comment

MeSH terms

Alopecia
Alopecia Areata* / drug therapy
Dermatologic Agents*
Glucocorticoids / therapeutic use
Humans
Janus Kinase Inhibitors* / therapeutic use

Substances

Janus Kinase Inhibitors
Dermatologic Agents
Glucocorticoids

Supplementary concepts

Diffuse alopecia